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Aging associated brain decline often result in some kind of dementia. Even when this is a complex
brain disorder a physical model can be used in order to describe its general behavior. This model
is based in first principles. A probabilistic model for the development of dementia is obtained and
fitted to some experimental data obtained from the Alzheimer’s Disease Neuroimaging Initiative. It
is explained how dementia appears as a consequence of aging and why it is irreversible.
I. INTRODUCTION
Dementia is a decline in mental ability, caused by dam-
age to brain cells, that interferes with daily life. Activities
of daily living are usually divided into basic and instru-
mental activities of daily living (IADL) [1, 2].
Several criteria and methods have been developed as
measuring tools to implement treatments and diagnoses
[3–6]. Despite the efforts developed in this field, the re-
lationship between IADL performance and mental activ-
ity is nowadays implemented using only simple statistical
approaches like Pearson’s or Spearman’s correlations.
On the other hand, catastrophe theory, particularly
cusp catastrophe models, have been used to describe sev-
eral psychological processes and human activities (drink-
ing, sexual interactions, nursing turnover, etc) [7–20].
However, in those studies, the data were fit to a cusp sur-
face without support from any phenomenological model,
so that the physical reasons of those processes remain
obscure. Here, we introduce a physical representation of
brain functions representing the brain tasks as creation
of networks between several neurons.
∗ Data used in preparation of this article were obtained from the
Alzheimer’s Disease Neuroimaging Initiative (ADNI) database
(adni.loni.usc.edu). As such, the investigators within the ADNI
contributed to the design and implementation of ADNI and/or
provided data but did not participate in analysis or writing
of this report. A complete listing of ADNI investigators can
be found at: http://adni.loni.usc.edu/wp-content/uploads/
how_to_apply/ADNI_Acknowledgement_List.pdf
II. THEORETICAL MODEL
In order to support a brain task, a network between
several neurons is created. This network is characterized
by a correlation length, x, [21] that depends both on the
topology and on the functionality of the network [22].
The degree of metabolic activity necessary to support the
task (and the network) is proportional to the volume of
the network determined by this correlation length. This
metabolic activity is equal to the energy used to maintain
the function of the neurons and their links, m0, plus the
energy required for the dynamic formation of the specific
network, mx.
However each brain task is not instantiated in its own
isolated network. Networks are shared between tasks
resulting in connectivity hubs [23]. When several cog-
nitive processes share the same network, they may do
so without a proportional increase in metabolic demand.
In order to characterize this phenomenon, we introduce
the concept of synaptic overlap. The degree of synaptic
overlap is proportional to the mean shared area, which
is energized by other processes along the network’s cor-
relation length. This characteristic network overlap has
been well described and is often referred to as a network
of networks [21].
So, the energetic balance of the network is summarized
as,
mx +m0 = ax
3
− br2x, (1)
where a and b are coefficients that convert the geomet-
ric characterization of the network into energy units and
2r characterizes the synaptic overlap. Equation (1) de-
scribes the possible values of the system in the space
determined by metabolic energy, synaptic overlap, and
correlation length (mx, r
2, x).
Since neuronal network set up is a synchronized re-
sponse to an electrical stimulus [24] it seems reasonable
that a faster network configuration involves more energy.
Let us now assume that the metabolic energy for a cogni-
tive task is proportional to the change rate of the corre-
lation length between neurons, that is, mx ∼ dx/dt. So,
equation (1) could be written as,
dx
dt
= x3 − βx− α =
∂U
∂x
, (2)
where now α and β are functions derived from equation
(1) that depend, in general, on metabolic energy, synaptic
overlap and time, and where U is a potential function
that corresponds to the Riemann-Hugoniot surface x3 −
βx − α = 0 for different α and β values. Equation (2),
or the equivalent potential, describes a cusp model [25,
26] that predicts sudden changes for x values; here α
and β are known as asymmetry control parameter and
bifurcation control parameter respectively.
Equation (2) is thus a deterministic model that relates
the energy in a cognitive task network to its correlation
length. However, the brain networks are subject to a high
level of noise [24]. The coupling of millions of neurons in
a network in order to do a task is necessarily subject to
random variations. In order to apply this model to real
data a probabilistic term should be added to the model.
This casts equation (2) into a stochastic differential
equation,
dx
dt
=
∂U
∂x
+ σ (x)W (t) , (3)
where σ (x) represents a diffusion process, that will be
assumed to be constant, and whichW (t) is a white noise
Wiener process. Notice that (3) is a Langevin equation
where the correlation length corresponds to the position
of the particle under the potential. The corresponding
Fokker-Planck equation for the probability density can
be written as,
∂ρ (x, t)
∂t
=
∂
∂x
[
∂U (x)
∂x
ρ (x, t)
]
+ σ
∂2
∂x2
ρ (x, t) . (4)
Nevertheless, equation (4) involves two different charac-
teristic times. Changes in x occur in the time of task
processing and brain network assembling, that is, in sec-
onds or minutes. Alterations of U , and consequently of
ρ, are due to the development of the neurodegenerative
diseases that act in a time scale of years. Since the vari-
ation of x in time is faster than the change of U , it can
be assumed that ρ changes very slowly over time, and
consequently ∂ρ/∂t ≃ 0.
From this, it is straightforward that,
ρ (x) = Ce−[
1
4
x4− 1
2
βx2−αx], (5)
where C is a normalization constant.
This last expression gives the probability density of
obtaining a network of size x for the steady state case,
that is, if the system varies slowly over time.
Since the probability density for a network with corre-
lation length x is known, the entropy of the set of net-
works, can be calculated as,
S (α, β) = −
∫
∞
0
ρ (y) ln (ρ (y)) dy, (6)
showing the natural evolution of the system.
III. DATA FITTING
In order to evaluate our model we fit some real data.
We should determine first how to model the correlation
length of the network. On one hand, neurodegenerative
diseases affect first the largest networks [27] and this is
reflected in the impairment of the more complex task.
On the other hand, we should consider the evolution of
the brain. From one organism to other, brain has growth
in size and complexity. While the new evolved life forms
are able to learn more complex task, their brain grow in
new layers and connected networks [28].
Notice also that high frequency activity in brain has
been associated to cognitive process [29] implying that
high functioning requires more energy.
So, the correlation length of the network will be mod-
eled as proportional to the network output. That is, a
bigger network is assumed as needed in order to accom-
plish a more difficult task.
Data used in the preparation of this article were ob-
tained from the Alzheimer’s Disease Neuroimaging Ini-
tiative (ADNI) database (adni.loni.usc.edu). The ADNI
was launched in 2003 as a public-private partnership, led
by Principal Investigator Michael W. Weiner, MD. The
primary goal of ADNI has been to test whether serial
magnetic resonance imaging (MRI), positron emission
tomography (PET), other biological markers, and clin-
ical and neuropsychological assessment can be combined
to measure the progression of mild cognitive impairment
(MCI) and early Alzheimer’s disease (AD).
ADNI is a global research effort devote to the research
of AD. The website group clinical, imaging, genetic and
biospecimen biomarkers from normal aging to demen-
tia stages. The standardized methods for imaging and
biomarker collection and analysis are intended for facili-
tating a cohesive research worldwide. ADNI provides the
collected information to all registered members.
A sample of 1351 subjects was selected from ADNI
cohort. All available data from these individuals gave
a total of 3025 study visits. We selected for analysis:
positron emission tomography fluorodeoxyglucose (FDG)
standard uptake value ratio, total brain volume (TBV),
intracranial volume (ICV), as well as the functional ac-
tivities questionnaire (FAQ) score. This questionnaire
is the information obtained from caregivers about IADL
3performance of patients. For each subject the brain ratio
(BR) was calculated as the ratio between TBV and ICV.
For each variable to be fitted into the model, FDG, BR
and FAQ, a linear transformation was applied to the data
in order to normalize it to the interval [0, 1]. In the case
of FAQ values the transformation was applied in opposite
direction. That is, the FAQ score increases as impairment
of IADL increases but the normalized variable decreases
as impairment of IADL increases.
The network output is proposed as proportional to
IADL; the bifurcation (β) and asymmetry (α) control
parameters are proposed as linear functions of the inde-
pendent variables [30]. That is,
x = w0 + w1f
α = a0 + a1u+ a2v
β = b0 + b1u+ b2v
, (7)
where f , u and v stand for the normalized values of FAQ,
FDG and BR and wi, ai and bi are fitting coefficients.
All the statistical procedures were made using R Statis-
tical Software [31]. The R package “cusp” calculate the
Cobb’s pseudo-R2 parameter as a measurement of the
goodness of fit [30]. Cobb’s pseudo-R2 and Pearson’s R2
corresponding to the linear model x = c0+c1f+c2u+c3v
were calculated and compared each other. The software
fits the data to the standard cusp model, where the bifur-
cation is centered at α = 0, β = 0 and x = 0. However,
by requiring to (7) that w0 = a0 = b0 = 0, as boundary
conditions, the data were fitted to (3).
IV. RESULTS
The Cobb’s correlation coefficient for the ADNI data
was pseudo-R2 = 0.68 that seems to be a much better fit
compared to the Pearson’s correlation coefficient R2 =
0.35 of the equivalent linear model. Fitting coefficients
of the Riemann-Hugoniot surface on (α, β, x) space were
w1 = 4.6, a1 = 6.6, a2 = 5.4, b1 = 2.8 and b2 = 0.1.
Figure 1 shows the control plane of the cusp model
and how the data distribute for α and β values. It can
be seen that there is a preferential direction along the
cusp surface, represented as a straight line. By trans-
lating and rotating the coordinate system, so that α lies
over this straight line and applying the boundary con-
ditions, x can be expressed in its "natural" coordinate
system (α′, β′). Figure 2 is the representation of the
data in the new coordinate system. It shows how the
data distribute for x values. Here, it can be seen that
two different results are possible, IADL task failure for
low values of IADL performance, and success, for high
values of IADL performance.
V. DISCUSSION
The entropy of the system, calculated according to (6)
and represented in Figure 3, defines the possible evolu-
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Figure 1. Control surface of the cusp model. Shadowed area
represents the bivaluated zone of the cusp. The straight line
represents the most probable trajectory on the plane. Arrow
shows the general direction of aging. Darkness of points is
proportional to the value of the correlation length.
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Figure 2. Change of possible values of the network correlation
length along the most probable trajectory represented by α′
line. The arrow shows the direction of aging. Darkness of
points is proportional to the value of the correlation length.
tion of the system in time. The system evolves in the
general direction of the known aging processes of brain,
represented with arrows in Figures 1 and 2. However,
the maximum value of entropy corresponds to the point
of α = 0 and β ≃ 2.15, very close to the point where the
data intersects the α = 0 plane (β = 2.06).
Older age is generally characterized by decreasing
brain volume [32] and a decline in brain glucose
metabolism [33–35]. Our model shows that even if this
declining process occurs slowly it could end in a catas-
trophic failures of IADL, that is, in dementia. Even
when older individuals are more likely to present multiple
pathologies [36] it has been observed that some very old
people get dementia without the presence of any pathol-
ogy. That is, even when age is associated to pathological
processes a non small percentage of the oldest people get
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Figure 3. Entropy of the system as a function of α′. The
maximum value of entropy is for α′ ≃ 6.5.
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Figure 4. Probability density of obtaining a network of size
x for different values of α′ along the most probable evolution
of the system.
dementia without any pathology [37].
As can be seen in Figure 4, the "high energy" states
produce only networks with high output. However, when
there is a loss of brain volume with older age and a lower
energy use, a point is reached where the probability of
producing a network with a very low output is not zero.
That is, the probability of task failure suddenly becomes
greater than zero. This probability of failure increases
along the aging process while the probability of success
decreases. At some point along this continuum, an in-
dividual will be diagnosed with dementia. At very low
values of BR and FDG the probability of success will be
zero.
Our results show that functional brain decline is clearly
observed through the measures of the energy consump-
tion (FDG) and the brain volume (BR). Dementia pro-
gression has been already associated with the lesser pres-
ence of brain energy consumption [38]. Furthermore, it
has been observed that the decline in energy consump-
tion increases in advanced disease stages [39] pointing to
a non linear relation between both magnitudes. Other
authors have linked the IADL impairment to brain atro-
phy [1, 40] and also abrupt changes of IADL for different
levels of brain atrophy have been observed [2], very sim-
ilar to those changes that our model predicts.
However, there is no deterministic relation between
those biomarkers and the onset of dementia. On the con-
trary, an individual’s decline could follow a random path
through the surface determined by Equation (2). Fur-
thermore, the precise moment when the subject falls into
dementia can not be predicted because it is governed by
a probability function.
Beyond statistical inference or linear relationships, a
few mathematical models link the brain functioning with
observed measures. However, these models are mainly
focused into capturing the patterns of the disease instead
of offering a general dynamics of the subject impairment
progression [41–43].
Here we offer a general framework that can be used
to test the weight of clinical variables over the disease.
Role of pathological variables could be easily determined
by rewriting α and β expression in equations (7). The
influence of comorbidities or other factors usually used
as covariables as age or genetic factors could be tested
the same way. Fitting coefficients should show if these
variables need to be taken into account. For instance,
it is clear that in equations (7) the brain atrophy can
be neglected from β since the coeffcient b2 is an order
of magnitude smaller than the others. However, the in-
clusion of new variables should modulate the trajectory
over the surface described by (2). So, the research over
several variables should require much more data in order
to show reliable results.
VI. CONCLUSIONS
It has been argued that dementia is the result of a
pathological process acting on the brain and is fundamen-
tally different from what is called healthy aging. How-
ever, based on the results of our model, normal aging re-
sults in a small, but continuous change in the brain that
can drive loss of performance in IADLs. This presents the
provocative possibility that at least in some case (e.g., the
oldest-old) a dementia syndrome could be an end-point
of otherwise normal aging.
However, the solution posed here is only for the steady
state. That is, the curve of Figure 2 represents the evo-
lution of system only if changes occur slowly. Stroke,
infections, and the like cause abrupt changes to the sys-
tem, and these are not accounted for in our model. We
do not exclude the possibility that dementia could also
appear as a consequence of sudden changes on the brain.
While our model explains the general behavior of the
data, the entropy of the system, shown in Figure 3 does
not explain more advanced cases of dementia. This could
5mean that the model should not be applied to the more
sparse networks that would be apparent in demented in-
dividuals.
This is a novel approach not only in the field of demen-
tia but more generally for neurodegenerative diseases.
By applying only first principles of physics, in this case
the laws of thermodynamics, we can show how cumula-
tive slow changes in the brain can trigger a catastrophic
change in the performance of the functional networks.
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